TABLE 2.
Baseline, mean (SE) | End of period, mean (SE) | Change from baseline, mean (95% CI) | DASH versus control, mean (95% CI) | P | |
---|---|---|---|---|---|
Overall, N = 55 (161 measurements) | |||||
Control, N = 28 | 5.35 (0.22) | 5.09 (0.21) | −0.26 (−0.50, −0.02) | Referent | Referent |
DASH, N = 27 | 5.00 (0.23) | 4.69 (0.18) | −0.31 (−0.55, −0.07) | −0.05 (−0.39, 0.28) | 0.77 |
Baseline serum urate < 6 mg/dL, N = 39 (115 measurements) | |||||
Control, N = 18 | 4.68 (0.17) | 4.54 (0.19) | −0.13 (−0.45, 0.18) | Referent | Referent |
DASH, N = 21 | 4.53 (0.19) | 4.38 (0.17) | −0.15 (−0.38, 0.08) | −0.01 (−0.41, 0.38) | 0.95 |
Baseline serum urate ≥6 mg/dL, N = 15 (44 measurements) | |||||
Control, N = 9 | 6.74 (0.14) | 6.24 (0.23) | −0.50 (−0.78, −0.22) | Referent | Referent |
DASH, N = 6 | 6.67 (0.28) | 5.78 (0.26) | −0.88 (−1.34, −0.42) | −0.38 (−0.92, 0.16) * | 0.16 |
Using a Wald test to assess for interaction yielded a P‐value of 0.0069.